Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,285 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Model 2 Clear all

Conditions: Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Multiple Chronic Conditions
Interventions: Patient-reported outcome measure, Comprehensive Medication Review, Pharmacist communication; Other
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Chronic Graft vs Host Disease, Chronic Graft-Versus-Host Disease
Interventions: Baricitinib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Substance Related Disorders, Mental Illness
Interventions: Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking (Veterans Edition), Getting To Outcomes; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 227 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 4
States / cities: Denver, Colorado • Washington D.C., District of Columbia • Bedford, Massachusetts + 1 more

Conditions: Celiac Disease
Interventions: Not listed
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Dallas, Texas • Seattle, Washington

Conditions: Cognitive Functioning of Healthy Individuals
Interventions: Philips IntelliSpace Cognition (ISC)., Paper-Pencil Tests.; Device · Diagnostic Test
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 508 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Newtown Square, Pennsylvania

Conditions: Caries
Interventions: 0 ppm F (placebo, negative control), 250 ppm F as NaF (dose-response control), 500 ppm F as NaF (dose-response control), 1100 ppm F as NaF (positive control); Drug
Lead sponsor: Domenick Zero; Other
Eligibility: 18 Years to 85 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Malaria
Interventions: KAF156, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hiv, HIV/AIDS, Disclosure
Interventions: Tough Talks Online, Tough Talks Clinic, Standard of Care; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 16 Years to 29 Years · Male only
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: HPV Vaccine, Provider Communication Practices, Vaccine Recommendation Practices
Interventions: QI coaching intervention; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Eosinophilic Esophagitis
Interventions: Omalizumab; Biological
Lead sponsor: O & O Alpan LLC; Other
Eligibility: 12 Years to 76 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Springfield, Virginia

Conditions: Aphasia, Malignant Brain Tumor
Interventions: LISTEN (AI-based AAC smartphone app); Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes, Food Insecurity, Rural Health
Interventions: Produce Prescription Program; Behavioral
Lead sponsor: University of Montana; Other
Eligibility: 55 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Arlee, Montana

Conditions: Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use
Interventions: Written Exposure Therapy (WET), Clinician Supported PTSD Coach App (CS-PTSD), Phone follow up, Primary Care Treatment Integrating Motivation and Exposure (PC-TIME); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Dover, New Jersey

Conditions: Uterine Fibroids
Interventions: ExAblate Treatment UF V2; Device
Lead sponsor: InSightec; Industry
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Stanford, California + 5 more

Conditions: Drug Abuse
Interventions: Strengths Based Case Management (SBCM), Motivational Enhancement Therapy (MET), Brief Informational Feedback (BIF) session; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 19 Years to 60 Years
Enrollment: 755 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Hematologic Malignancy
Interventions: Nite2Day+; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Feeding Behavior, Preterm Infant, Stress, Mother-Infant Interaction
Interventions: Stress and Feeding (SAFE); Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Type 1 Diabetes Mellitus
Interventions: CGM and Insulin Pump, Closed-Loop Control System; Device
Lead sponsor: Sansum Diabetes Research Institute; Other
Eligibility: 21 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 3
States / cities: Santa Barbara, California • Rochester, Minnesota • Charlottesville, Virginia

Conditions: Program Evaluation, Child Sexual Abuse, Perpetration of Child Sexual Abuse, Prevention Intervention
Interventions: Help Wanted Prevention Intervention, Waitlist Control; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Male only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Human Papillomavirus Vaccines, Adolescent Health Services
Interventions: Project ECHO, Announcement Approach Training, Recall notices; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Vitiligo
Interventions: Rapamycin, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 13 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: HIV/AIDS, Diabetes Mellitus, Type 2, Hypertension
Interventions: Medication optimization intervention; Other
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 2
States / cities: Fort Worth, Texas

Conditions: Hand Washing
Interventions: Organization Model, Data Feedback Model; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 1,624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 1 Diabetes Mellitus
Interventions: Predictive Low Glucose Suspend Algorithm ON, Predictive Low Glucose Suspend Algorithm OFF; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 46 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Stanford, California • Aurora, Colorado

Search by objective public record fields.

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

MISSION-Vet HUD-VASH Implementation Study

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

Norms Expansion and Validation for IntelliSpace Cognition

Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model

Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model

Tough Talks: A Disclosure Intervention for HIV+ Young Men Who Have Sex With Men (YMSM)

Mobile Coaching to Improve HPV Vaccine Delivery

Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model

Listen Aphasia Pilot Study

The Food for Health Study

Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Project Health Link: Connecting Patients With Services

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Stress and Feeding (SAFE): A Pilot Intervention for Mothers and Their Preterm Infants

At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation

Help Wanted: Evaluating a Prevention Intervention for People With Sexual Interest in Children

HPV Vaccine Communication ECHO for Primary Care Clinics

Daily Topical Rapamycin for Vitiligo

Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)

Increasing Evidence-based Clinical Practices in VA

Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study